Brickell Biotech Inc expected to post a loss of $1.44 a share - Earnings Preview

Fresh Tracks Therapeutics

10/08/2022 03:03

* Brickell Biotech Inc  BBI.OQ   BBI.O  is expected to show
a rise
in quarterly revenue when it reports  results on August 11. 
    * The Boulder Colorado-based  company is expected to report 
a
1,976.4% increase in revenue to $3.135 million from $151
thousand a year ago, according to the mean estimate from 3
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Brickell Biotech
Inc is
for a loss of $1.44 per share. For the same quarter last year,
the company reported a loss of $7.20 per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Brickell
Biotech
Inc is $45​, above​ its last closing price of $3.63. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2022  -2.55       -2.59      -3.60     Missed  -39.1
 Dec. 31 2022  -3.84       -3.82      -2.70     Beat    29.4
 Sep. 30 2021              -5.62      -7.20     Missed  -28​
 Jun. 30 2021  -6.30       -5.62      -7.20     Missed  -28
 ​​Mar.        -5.17       -5.17      -6.75     Missed  -30.4
 31 2021                                                
 Dec. 31 2020  -4.05       -4.05      -6.75     Missed  -66.7​
 Sep. 30 2020  -8.33       -8.32      -6.75     Beat    18.9
 This summary was machine generated August 10 at 02:02 GMT.  All
figures in US dollars  unless otherwise stated